97 related articles for article (PubMed ID: 1682166)
1. Is multidrug resistance relevant in breast cancer?
Wishart GC; Kaye SB
Eur J Surg Oncol; 1991 Oct; 17(5):485-8. PubMed ID: 1682166
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance in chemotherapy for breast cancer.
Saeki T; Tsuruo T; Sato W; Nishikawsa K
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
[TBL] [Abstract][Full Text] [Related]
3. The multidrug resistance phenotype in human cancer.
Cordon-Cardo C; O'Brien JP
Important Adv Oncol; 1991; ():19-38. PubMed ID: 1678363
[No Abstract] [Full Text] [Related]
4. A new functional role for P-glycoprotein: efflux pump for benzo(alpha)pyrene in human breast cancer MCF-7 cells.
Yeh GC; Lopaczynska J; Poore CM; Phang JM
Cancer Res; 1992 Dec; 52(23):6692-5. PubMed ID: 1358437
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance mediated by P-glycoprotein in haematological malignancies.
Pasman PC; Schouten HC
Neth J Med; 1993 Jun; 42(5-6):218-31. PubMed ID: 8104318
[TBL] [Abstract][Full Text] [Related]
6. Intracellular P-glycoprotein in multidrug resistant tumor cells.
Arancia G; Molinari A; Calcabrini A; Meschini S; Cianfriglia M
Ital J Anat Embryol; 2001; 106(2 Suppl 1):59-68. PubMed ID: 11729998
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance.
Moscow JA; Cowan KH
Cancer Chemother Biol Response Modif; 1991; 12():91-109. PubMed ID: 1681846
[No Abstract] [Full Text] [Related]
8. The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen.
Ross DD; Gao Y; Yang W; Leszyk J; Shively J; Doyle LA
Cancer Res; 1997 Dec; 57(24):5460-4. PubMed ID: 9407950
[TBL] [Abstract][Full Text] [Related]
9. [Glycoprotein in multidrug-resistant malignancies--clinical implications].
Ellis A; Lishner M; Manor J; Ravid M
Harefuah; 1994 Mar; 126(6):334-7. PubMed ID: 7910806
[No Abstract] [Full Text] [Related]
10. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
Kaye SB
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
Politi PM; Arnold ST; Felsted RL; Sinha BK
Mol Pharmacol; 1990 Jun; 37(6):790-6. PubMed ID: 1972771
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
Willman CL
Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
[TBL] [Abstract][Full Text] [Related]
13. Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells.
Phang JM; Poore CM; Lopaczynska J; Yeh GC
Cancer Res; 1993 Dec; 53(24):5977-81. PubMed ID: 7903198
[TBL] [Abstract][Full Text] [Related]
14. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells.
Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C
Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965
[TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance in pediatric malignancies.
Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein.
Shi Z; Liang YJ; Chen ZS; Wang XH; Ding Y; Chen LM; Fu LW
Oncol Rep; 2007 Apr; 17(4):969-76. PubMed ID: 17342344
[TBL] [Abstract][Full Text] [Related]
17. Molecular targets in oncology: implications of the multidrug resistance gene.
Lum BL; Gosland MP; Kaubisch S; Sikic BI
Pharmacotherapy; 1993; 13(2):88-109. PubMed ID: 8097038
[TBL] [Abstract][Full Text] [Related]
18. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
Ihnat MA; Lariviere JP; Warren AJ; La Ronde N; Blaxall JR; Pierre KM; Turpie BW; Hamilton JW
Clin Cancer Res; 1997 Aug; 3(8):1339-46. PubMed ID: 9815817
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of multidrug resistance in tumor cells.
Roninson IB
Clin Physiol Biochem; 1987; 5(3-4):140-51. PubMed ID: 2887329
[TBL] [Abstract][Full Text] [Related]
20. Identification of a P-glycoprotein-related protein (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells.
Kawai K; Kusano I; Ido M; Sakurai M; Shiraishi T; Yatani R
Biochem Biophys Res Commun; 1994 Jan; 198(2):804-10. PubMed ID: 7905266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
